Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study

Abstract BackgroundPatients with cancer often face significant financial challenges, known as financial toxicity (FT), which is associated with reduced quality of life. Patients with hematologic malignancies (HMs) are especially vulnerable due to intensive and prolonged treatm...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Lemchukwu Amaeshi, Lauren Laufer, Kateryna Fedorov, Alex Sisto, David Levitz, Rosmi Mathew, Karen Wright, Dennis Cooper, Mendel Goldfinger, Ioannis Mantzaris, R Alejandro Sica, Kira Gritsman, Marina Konopleva, Ridhi Gupta, Noah Kornblum, Chenxin Zhang, Mimi Kim, Amit Verma, Bruce Rapkin, Aditi Shastri, Nishi Shah
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	JMIR Publications 2026-01-01
Seri Bilgileri:	JMIR Cancer
Online Erişim:	https://cancer.jmir.org/2026/1/e68101
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study

Benzer Materyaller